Scientists test Next-Gen Nasal-Response COVID booster
NCT ID NCT07095231
Summary
This early-stage study is testing the safety and immune response of a new COVID-19 booster vaccine called STX-S. It will enroll 60 healthy adults who have already received their primary COVID vaccines and at least one booster. Researchers will give participants a single shot at one of three dose levels to check for side effects and see if it boosts antibodies in the blood and the nose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaiser Permanente Washington Health Research Institute
Seattle, Washington, 98101-1466, United States
-
The University of Washington - Virology Research Clinic
Seattle, Washington, 98104, United States
-
University of Rochester Medical Center - Vaccine Research Unit
Rochester, New York, 14642-0001, United States
Conditions
Explore the condition pages connected to this study.